Our data demonstrated seven potential risk factors for MHE in patients with HCC, including protein levels of IL-1β, IL-6, IFNγ, IFNλ3 and IL-17a, and mRNA levels of IL-6 and IFNγ. This evidence concerns the gene IL1B and hepatocellular carcinoma.